Market Research Report
Asia-pacific Medical Enzymes Market Forecast 2022-2030
|Asia-pacific Medical Enzymes Market Forecast 2022-2030|
Published: June 21, 2022
Content info: 170 Pages
Delivery time: 2-3 business days
The Asia-Pacific medical enzymes market is set to develop with a CAGR of 7.49% across the estimated period of 2022 to 2030. Some of the key aspects fueling the market's growth include poor dietary habits prevalent in developing countries, rapid industrialization, increasing weight and eating routine concerns, and the rise in research and development expenditure.
The Asia-Pacific medical enzymes market growth evaluation covers the analysis of Thailand, South Korea, China, Indonesia, India, Vietnam, Japan, Australia & New Zealand, and Rest of Asia-Pacific. India is one of the largest providers of drugs globally. Moreover, the country is also a key supplier of low-cost vaccines, primarily owing to their high quality and affordability. As per the data issued by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, India is the third-largest market for APIs across the world, as well.
Moreover, with the National Pharmaceutical Pricing Policy, essential medications are also available in India at reasonable prices. The low cost of production, in addition to increased research and development, further enhance the efficacy of pharmaceutical companies in the country. In this regard, according to the IBEF, India's drugs and pharma exports captured $5.78 billion from April 2021 to June 2021. As a result, these factors are anticipated to propel the medical enzymes market growth in the Asia-Pacific over the forecast years.
Well-established companies operating in the market include: Amano Enzyme, Advanced Enzyme Technologies, etc.